Avalo Therapeutics, Inc. · NASDAQ:AVTX

Nantahala Capital Management, LLC reported a 8.43% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed May 15, 2025

Nantahala Capital Management, LLC reported a 8.43% stake in Avalo Therapeutics, Inc., 900,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).

Stake
8.43%
Shares
900,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC8.43%900,000
Wilmot B. Harkey8.43%900,000
Daniel Mack8.43%900,000

Source

View original at SEC

Related